WO2007103492A3 - Cellular predictive models for toxicities - Google Patents

Cellular predictive models for toxicities Download PDF

Info

Publication number
WO2007103492A3
WO2007103492A3 PCT/US2007/005916 US2007005916W WO2007103492A3 WO 2007103492 A3 WO2007103492 A3 WO 2007103492A3 US 2007005916 W US2007005916 W US 2007005916W WO 2007103492 A3 WO2007103492 A3 WO 2007103492A3
Authority
WO
WIPO (PCT)
Prior art keywords
toxicities
predictive models
models
stimuli
subset
Prior art date
Application number
PCT/US2007/005916
Other languages
French (fr)
Other versions
WO2007103492A2 (en
Inventor
Eugeni Vaisberg
Vadim Kutsyy
Jeffrey Finer
Original Assignee
Cytokinetics Inc
Eugeni Vaisberg
Vadim Kutsyy
Jeffrey Finer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB0605362A external-priority patent/GB2435926A/en
Application filed by Cytokinetics Inc, Eugeni Vaisberg, Vadim Kutsyy, Jeffrey Finer filed Critical Cytokinetics Inc
Publication of WO2007103492A2 publication Critical patent/WO2007103492A2/en
Publication of WO2007103492A3 publication Critical patent/WO2007103492A3/en

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/5014—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing toxicity
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/5044—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics involving specific cell types
    • G01N33/5067—Liver cells
    • G—PHYSICS
    • G06—COMPUTING; CALCULATING OR COUNTING
    • G06V—IMAGE OR VIDEO RECOGNITION OR UNDERSTANDING
    • G06V20/00—Scenes; Scene-specific elements
    • G06V20/60—Type of objects
    • G06V20/69—Microscopic objects, e.g. biological cells or cellular parts
    • G06V20/695—Preprocessing, e.g. image segmentation

Abstract

Methods for generating models for predicting biological activity of a stimulus test population of cells are provided. The models may be used to classify or predict the effect of stimuli on cells. In certain embodiments, the methods involve receiving data comprising values for dependent variables associated with stimuli; preparing a set of cell populations based on the data received; identifying a subset of the cell populations to be used in generating a model from data associated with the subset, wherein the model is provided to predict activity of a test population.
PCT/US2007/005916 2006-03-09 2007-03-07 Cellular predictive models for toxicities WO2007103492A2 (en)

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
US78103306P 2006-03-09 2006-03-09
US60/781,033 2006-03-09
US78267606P 2006-03-14 2006-03-14
US60/782,676 2006-03-14
GB0605362A GB2435926A (en) 2006-03-09 2006-03-17 Cellular predictive models for phospholipidosis
GB0605362.3 2006-03-17

Publications (2)

Publication Number Publication Date
WO2007103492A2 WO2007103492A2 (en) 2007-09-13
WO2007103492A3 true WO2007103492A3 (en) 2008-10-23

Family

ID=38475559

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2007/005916 WO2007103492A2 (en) 2006-03-09 2007-03-07 Cellular predictive models for toxicities

Country Status (1)

Country Link
WO (1) WO2007103492A2 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5406019B2 (en) 2006-05-17 2014-02-05 セルーメン、インコーポレイテッド Method for automated tissue analysis
EP2686688B1 (en) 2011-03-17 2019-05-08 Cernostics, Inc. Systems and compositions for diagnosing barrett's esophagus and methods of using the same
RU2014133547A (en) * 2012-01-18 2016-03-10 Дженентек, Инк. WAYS OF APPLICATION OF FGF19 MODULATORS

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040086873A1 (en) * 2002-10-31 2004-05-06 Johnson Peter C. System and method of generating and storing correlated hyperquantified tissue structure and biomolecular expression datasets
US20050014217A1 (en) * 2003-07-18 2005-01-20 Cytokinetics, Inc. Predicting hepatotoxicity using cell based assays
US6873914B2 (en) * 2001-11-21 2005-03-29 Icoria, Inc. Methods and systems for analyzing complex biological systems

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6873914B2 (en) * 2001-11-21 2005-03-29 Icoria, Inc. Methods and systems for analyzing complex biological systems
US20040086873A1 (en) * 2002-10-31 2004-05-06 Johnson Peter C. System and method of generating and storing correlated hyperquantified tissue structure and biomolecular expression datasets
US20050014217A1 (en) * 2003-07-18 2005-01-20 Cytokinetics, Inc. Predicting hepatotoxicity using cell based assays

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
ERLER, BS ET AL.: "A Study of Hepatocellular Carcinoma Using Morphometric and Densitometric Image Analysis.", AMERICAN JOURNAL OF CLINICAL PATHOLOGY., vol. 100, 1993, pages 151 - 157, XP055354593 *
ERLER, BS ET AL.: "Methods in Laboratory Investigation: Image Analysis.and Diagnostic Classification of Hepatocellular Carcinoma Using Neural Networks and Multivariate Discriminant Functions.", LABORATORY INVESTIGATION., vol. 7 1, no. 3, 1994, pages 446 - 451 *

Also Published As

Publication number Publication date
WO2007103492A2 (en) 2007-09-13

Similar Documents

Publication Publication Date Title
WO2007103532A3 (en) Normalizing cell assay data for models
WO2007103406A3 (en) Cellular predictive models for toxicities
WO2007084374A3 (en) Random forest modeling of cellular phenotypes
MX2010004257A (en) Wo 2009082605 a1 20090702.
EP2244140A3 (en) Process Simulation Utilizing Component-Specific Consumption Data
WO2008102602A1 (en) Organ regeneration method utilizing blastocyst complementation
GB2474146A (en) Methods of determining the health status of an individual
WO2009086427A8 (en) Systems and methods for workflow processing
WO2010018542A3 (en) System and method for dynamic cardiac analysis, detection, monitoring, prediction, and response using cardio-physiological mathematical modeling
WO2009056992A3 (en) Reservoir fracture simulation
WO2004081205A8 (en) Differentiation of human embryonic stem cells to cardiomyocytes
NZ749626A (en) Genetically modified non-human animals and methods of use thereof
EP4306955A3 (en) Integrated functional and molecular profiling of cells
WO2007103531A3 (en) Cellular predictive models for toxicities
WO2009089294A3 (en) Methods and systems for generating software quality index
WO2006122295A8 (en) Methods of monitoring functional status of transplants using gene panels
DE602006014676D1 (en) FESTPOLYMER ELECTROLYTE MEMBRANE, PRODUCTION METHOD AND FUEL CELL
WO2012024546A3 (en) Incorporation of health measurments in analysis and interpretation of functional biological response data
CY1111769T1 (en) CELL PREPARATION
HK1093755A1 (en) Method for differentiating mesenchymal stem cell into neural cell
WO2006055338A3 (en) Methods and systems for identifying and isolating stem cells and for observing mitochondrial structure and distribution in living cells
DE602006009839D1 (en) USING SEQUENTIAL CLUSTERING FOR INSTANCE SELECTION IN MACHINE STATE MONITORING
WO2009032827A3 (en) Electroporative flow cytometry
GB2411281B (en) Storage device
WO2007103535A3 (en) Cellular predictive models for toxicities

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application
NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 07752603

Country of ref document: EP

Kind code of ref document: A2